About Allovir (ALVR)
AlloVir, Inc. is a late clinical-stage cell therapy company. The Company is engaged in developing allogeneic T-cell therapies to treat and prevent viral diseases. Its virus-specific T cell (VST) therapy platform enables to generate VSTs designed to r... Read more
- USD4.53
- USD5.99
- USD4.43
- USD10.29
- 1.10%
- --
- 834.00
- 180.33k
- 371M
- 3.17
- 20.50%
Stock News
1 hour ago
Britain to explore wider access to weight-loss drugs in two-year pilot
Reuters
1 hour ago
Tesla Gears Up For India Entry, Plans To Assemble, Set Up Vendor Base In China's South Asian Rival
Yahoo
2 hours ago
STMicroelectronics and Sanan plan silicon carbide venture in China
Yahoo
3 hours ago
STMicroelectronics and Sanan Optoelectronics to advance Silicon Carbide ecosystem in China
Yahoo
Unlock More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
